AlenCiken

U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial

OTC:RVVTF   Revive Therapeutics Ltd
UPDATE - Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

https://www.globenewswire.com/news-relea...


Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.